Cite
HARVARD Citation
Assal, A. et al. (n.d.). Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor. Leukemia & lymphoma. 57 (10), pp. 2452-2455. [Online].